Extreme hypofractionation of radiotherapy is a novel treatment modality for patients with organ-confined prostate cancer. Arcangeli and Greco summarize the results of clinical trials investigating moderate and extreme hypofractionation regimens, highlight challenges to the routine use of extreme hypofractionation and discuss areas for further clinical research.
- Stefano Arcangeli
- Carlo Greco
